Dart NeuroScience, a pharmaceutical company based in San Diego and funded by Ken Dart, announced its closure on 7 December 2017. The company’s mission was to research and develop new methods to improve memory function. Despite an investment in excess of $700 million dollars over the past decade, and despite the stellar effort of a capable and dedicated team of highly qualified scientists, Dart NeuroScience has not generated adequate signs of any human memory improvement or motor rehabilitation. The investment required to continue even some of these programmes would run into several billion dollars, with questionable odds of success. As it is clear the investment is not viable, the Board made the pragmatic decision to wind up operations. Every effort will be made to support and assist staff as they seek new opportunities.
For media enquiries, please contact Pilar Bush, Dart Enterprises Executive Vice President of Marketing, at firstname.lastname@example.org.
In other news